BioGaia signs with Ewopharma for CE Europe
Swedish biotech BioGaia has signed a new agreement with Ewopharma to distribute its probiotic drops and tablets in a number of new markets in Central Eastern Europe.
News, Analysis & Insights on Nutrition, Supplements, and Health
Swedish biotech BioGaia has signed a new agreement with Ewopharma to distribute its probiotic drops and tablets in a number of new markets in Central Eastern Europe.
Preview
Industry executives from across the globe are making their way to Las Vegas in time for the opening of SupplySide West - and event said to be the biggest in its history and one of the best opportunities in the annual calendar for introducing new...
French scientists, in collaboration with Nestlé Research Centre, have shown that an in vitro digestion model could be a valuable tool to quantify potential bioaccessibility of vitamin E and carotenoids from functional food.
Researchers at the University of Virginia are starting a new project, funded by the National Cancer Institute, to unlock the secrets behind broccoli's potential anti-cancer benefits.
Increasing vitamin D levels may help curb the development and progression of breast cancer, suggests a small study from Imperial College London.
A major project to boost standards in African medicinal plants and spur European trade has yielded its first results, but more support is sought to ensure its long-term survival.
Health Sciences Group is intending to acquire specialty tea and food company Kalahari - the first acquisition since its focus shift from ingredients to branded finished foods and an indication of its new, market-driven strategy.